Clincosm LogoSign in Get a demo

Evaluation of Hand Grip Strength in Pregnant COVID-19 Patients

Sponsor
Karaman Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05970874
Collaborator
(none)
23
Enrollment
1
Location
5.9
Actual Duration (Months)
3.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.

Condition or Disease Intervention/Treatment Phase
  • Device: Hand grip strength measureme

Detailed Description

Covid 19 is the disease defined for strains infected with severe acute respiratory syndrome coronavirus 2(Sars-CoV-2). Hand grip strength is a non-invasive, easily applicable, objective parameter. It was presented as a cross-sectional, single-center, retrospective case series. Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19 were included in the study. The relationship between patients' musculoskeletal symptoms and signs and hand grip strength was investigated.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
23 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Musculoskeletal Pain in Pregnant Infected With COVID-19, Evaluation of Fatigue and Muscle Grip Strength
Actual Study Start Date :
Dec 1, 2021
Actual Primary Completion Date :
May 1, 2022
Actual Study Completion Date :
May 30, 2022

Arms and Interventions

Arm Intervention/Treatment
pregnant covid 19 patients

pregnant covid 19 patients

Device: Hand grip strength measureme
Hand grip strength (HSG) was measured in kg with the CAMRY Digital Hand Dynamometer (Model No. EH101, CAMRY).

Outcome Measures

Primary Outcome Measures

  1. Hand grip strength assessment [The first 24 hours after admission to the service.]

    Hand grip strength assessment in pregnancy Covid 19.

Secondary Outcome Measures

  1. symptoms [The first 24 hours after admission to the service.]

    Common symptoms of pregnant Covid 19 patients.

  2. laboratory findings [The first 24 hours after admission to the service.]

    Common laboratory findings of pregnant Covid 19 patients.

  3. Vaccine [pre-infection period was questioned]

    Vaccine rate of pregnant Covid 19 patients.

  4. Smoking [pre-infection period was questioned]

    Smoking rate of pregnant Covid 19 patients.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pregnant women with a positive Polymerase Chain Reaction (PCR) diagnosis of Covid 19
Exclusion Criteria:
  • Those with orthopedic defects in the dominant hand and wrist and those with hand, wrist and shoulder involvement on the side of the measurement related to rheumatological diseases were excluded from the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hatice Toprak Karaman Merkez Turkey 70200

Sponsors and Collaborators

  • Karaman Training and Research Hospital

Investigators

  • Principal Investigator: Hatice Toprak, dr.tprk@hotmail.com

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Karaman Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT05970874
Other Study ID Numbers:
  • 06-2022/10
First Posted:
Aug 1, 2023
Last Update Posted:
Aug 8, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Karaman Training and Research Hospital
COVID-19
Musculoskeletal Symptom
Hand Grip Muscle Streng
Additional relevant MeSH terms:
COVID-19

Study Results

No Results Posted as of Aug 8, 2023